IDEXX Laboratories Inc.

NASDAQ: IDXX · Real-Time Price · USD
491.88
1.90 (0.39%)
At close: May 09, 2025, 3:59 PM
492.20
0.07%
After-hours: May 09, 2025, 04:59 PM EDT

IDEXX Laboratories Statistics

Share Statistics

IDEXX Laboratories has 80.42M shares outstanding. The number of shares has increased by -1.87% in one year.

Shares Outstanding 80.42M
Shares Change (YoY) -1.87%
Shares Change (QoQ) -1.03%
Owned by Institutions (%) 87.28%
Shares Floating n/a
Failed to Deliver (FTD) Shares 58
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 3M, so 3.7% of the outstanding shares have been sold short.

Short Interest 3M
Short % of Shares Out 3.7%
Short % of Float 4.83%
Short Ratio (days to cover) 2.44

Valuation Ratios

The PE ratio is 38.4 and the forward PE ratio is 35.87. IDEXX Laboratories's PEG ratio is 6.51.

PE Ratio 38.4
Forward PE 35.87
PS Ratio 8.75
Forward PS 7.5
PB Ratio 21.37
P/FCF Ratio 42.72
PEG Ratio 6.51
Financial Ratio History

Enterprise Valuation

IDEXX Laboratories has an Enterprise Value (EV) of 34.79B.

EV / Sales 8.93
EV / EBITDA 27.27
EV / EBIT 37.45
EV / FCF 43.6

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.62.

Current Ratio 1.31
Quick Ratio 0.95
Debt / Equity 0.62
Debt / EBITDA 0.77
Debt / FCF 1.24
Interest Coverage 36.16

Financial Efficiency

Return on Equity is 55.65% and Return on Invested Capital is 33.87%.

Return on Equity 55.65%
Return on Assets 26.96%
Return on Invested Capital 33.87%
Revenue Per Employee $354,318.55
Profits Per Employee $80,715.18
Employee Count 11,000
Asset Turnover 1.18
Inventory Turnover 3.98

Taxes

Income Tax 221.96M
Effective Tax Rate 20%

Stock Price Statistics

The stock price has increased by -2.2% in the last 52 weeks. The beta is 1.52, so IDEXX Laboratories's price volatility has been higher than the market average.

Beta 1.52
52-Week Price Change -2.2%
50-Day Moving Average 425.21
200-Day Moving Average 447.34
Relative Strength Index (RSI) 72.83
Average Volume (20 Days) 876,945

Income Statement

In the last 12 months, IDEXX Laboratories had revenue of 3.9B and earned 887.87M in profits. Earnings per share was 10.77.

Revenue 3.9B
Gross Profit 2.38B
Operating Income 1.13B
Net Income 887.87M
EBITDA 1.28B
EBIT 1.14B
Earnings Per Share (EPS) 10.77
Full Income Statement

Balance Sheet

The company has 288.27M in cash and 986.95M in debt, giving a net cash position of -698.68M.

Cash & Cash Equivalents 288.27M
Total Debt 986.95M
Net Cash -698.68M
Retained Earnings 5.33B
Total Assets 3.21B
Working Capital 181.4M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 929M and capital expenditures -130.92M, giving a free cash flow of 798.08M.

Operating Cash Flow 929M
Capital Expenditures -130.92M
Free Cash Flow 798.08M
FCF Per Share 9.68
Full Cash Flow Statement

Margins

Gross margin is 61.04%, with operating and profit margins of 28.95% and 22.78%.

Gross Margin 61.04%
Operating Margin 28.95%
Pretax Margin 28.48%
Profit Margin 22.78%
EBITDA Margin 32.73%
EBIT Margin 28.95%
FCF Margin 20.48%

Dividends & Yields

IDXX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 2.6%
FCF Yield 2.34%
Dividend Details

Analyst Forecast

The average price target for IDXX is $535, which is 9.2% higher than the current price. The consensus rating is "Buy".

Price Target $535
Price Target Difference 9.2%
Analyst Consensus Buy
Analyst Count 8
Stock Forecasts

Stock Splits

The last stock split was on Jun 16, 2015. It was a forward split with a ratio of 2:1.

Last Split Date Jun 16, 2015
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 15.48
Piotroski F-Score 7